ArticleJCO precision oncologyPublished
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- JCO precision oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Melanoma; Azetidines; Piperidines; Proto-Oncogene Proteins B-raf; Antineoplastic Agents; Mutation; Vemurafenib
- PubMed ID
- 38096472
- PubMed Central ID
- PMC10735080
- Open access
- Yes, free to read
- Added to directory
- Source checked